Atlas Trials

Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression

Clinical trial NCT02431169 · TERMINATED

Trial details

NCT number
NCT02431169
Sponsor
Washington University School of Medicine
Status
TERMINATED
Study type
OBSERVATIONAL
Carcinoma, Non-Small-Cell-LungNon-Small Cell Lung CancerNonsmall Cell Lung Cancer
Start date
2015-04-30
Primary completion
2019-06-27
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.